4//SEC Filing
Bielasz Jennifer Kathleen 4
Accession 0001514346-12-000003
CIK 0001080709other
Filed
Mar 29, 8:00 PM ET
Accepted
Mar 30, 7:13 PM ET
Size
10.9 KB
Accession
0001514346-12-000003
Insider Transaction Report
Form 4
Bielasz Jennifer Kathleen
Sr. Dir. of Accounting & Cont.
Transactions
- Sale
Common Stock
2012-03-29$3.04/sh−6,250$19,001→ 9,350 total - Exercise/Conversion
Common Stock
2012-03-29$1.49/sh+6,250$9,313→ 15,600 total - Sale
Common Stock
2012-03-29$3.01/sh−4,550$13,696→ 4,800 total - Exercise/Conversion
Employee Stock Option (right to buy)
2012-03-29−6,250→ 18,750 totalExercise: $1.49Exp: 2021-03-15→ Common Stock (6,250 underlying)
Holdings
- 30(indirect: By son)
Common Stock
Footnotes (2)
- [F1]The reporting person paid the issuer a total of $34.20 for the difference between the $1.90 per share price of the 30 shares her son purchased on February 1, 2012, and the $3.0401 per share price of 30 of the shares sold by the reporting person and reported on this line.
- [F2]The options, representing the right to purchase a total of 25,000 shares, vest in four equal annual installments beginning on March 15, 2012, which was the first anniversary of the date on which the options were granted. The options are exercisable once vested.
Documents
Issuer
ARENA PHARMACEUTICALS INC
CIK 0001080709
Entity typeother
Related Parties
1- filerCIK 0001514346
Filing Metadata
- Form type
- 4
- Filed
- Mar 29, 8:00 PM ET
- Accepted
- Mar 30, 7:13 PM ET
- Size
- 10.9 KB